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Bile acid chemistry 
Bile acids were isolated from bile in the 19th century, and the field of bile acid 
chemistry preceded the development of classical biochemistry.1 Bile acids are 
amphipathic (hydrophilic and hydrophobic face) end products of cholesterol metabolism 
that facilitate lipids or vitamins absorption in the intestine. Bile acids are synthesized in 
the liver as primary bile acids from oxidation of cholesterol by cytochrome P-450 
enzyme family, and are conjugated with either glycine or taurine by amidation.2 Normal 
conjugated form of glycine and taurine are existed 3:1 ratio in human bile, but dominant 
bile acid classes are dependent on each animal species. Bile acids are released into the 
proximal intestine, and reabsorbed in the distal intestine via the portal vein, an 
enterohepatic circulation system. And a part of bile acids are modified by bacteria to 
termed secondary bile acids. The complexity of bile acid nomenclature can be explained 
by the evolution of multiple biochemical pathways that serve to convert cholesterol.3  
 
Pathway of bile acid biosynthesis 
There are two major bile acid biosynthetic pathways in the liver, the neutral and 
alternative pathway.4 The neutral pathways are initiated by cholesterol 7-hydroxylase 
(CYP7A1), the rate-limiting step. Sterol 12-hydroxylase (CYP8B1) determines the 
ratio of cholic acid to chenodeoxycholic acid. The neutral bile acid biosynthetic 
pathway consists of least 16 enzymatic steps leading to the formation of cholic acid and 
chenodeoxycholic acid. The alternative pathways are initiated by mitochondrial sterol 
27-hydroxylase (CYP27A1), the rate-limiting step appears to be transport of cholesterol 
to the inner mitochondrial membrane. In humans, the neutral pathway is the major 
pathway of synthesis under normal physiological conditions. While CYP7A1 is 
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expressed only in hepatocytes, mitochondrial CYP27A1 is expressed in many different 
tissues, a potential role in feedback regulation of cholesterol. 25-hydroxycholesterol 
and its sulfated form in alternative pathways may play potential regulatory oxysterol 
and metabolite. STAR D1, steroidogenic acute regulatory protein D1; SULT2B1b, 
hydroxycholesterol sulfotransferase 2B1b; CYP7B1, oxysterol 7-hydroxylase; BAL, 
















































Conjugated primary bile acids





Bile acids turn into hormones 
Recently, bile acids emerged as complex metabolic integrators and versatile 
signaling molecules endowed with systemic endocrine functions.5-6 Bile acids have 
many physiological functions such as regulation of gene expression involved in 
cholesterol, glucose, and their own homeostasis. Bile acids are ligands for G-protein 
coupled receptors (GPCR) such as TGR5 and modulate several nuclear hormone 
receptors including farnesoid X receptor (FXR).7-8 Through activation of these versatile 
signaling molecules, bile acids have been shown to regulate not only their own 
synthesis and enterohepatic circulation, but also triglyceride, cholesterol, energy, and 
glucose homeostasis. These bile acid controlled signaling pathways have become the 
source of promising novel drug targets to treat common metabolic and hepatic diseases 
such as obesity, type 2 diabetes, hypertriglyceridaemia, atherosclerosis and 
non-alcoholic steatohepatitis. And some of bile acid related drugs and FXR antagonists 
are in clinical or preclinical phase. Moreover, physiological impact of bile acid 
signaling extends beyond the strict control of metabolism, as important roles of bile 





































Serum proteome for biomarker development 
 
Good biomarkers are measurable from non-invasive test, and indicators of a 
biological state, disease risk or stage, early disease detection and classification of 
disease type or organ. And, in the future, biomarker is an indicator for personalized 
therapy or a target of drug. Because biomarkers in clinical diagnosis are usually 
development of a blood test, blood is a logical body fluid for biomarker discovery. 
Human plasma is high complexity and large dynamic concentration range of proteins up 
to 12 orders identified by the HUPO plasma proteome project.9 Plasma proteins can be 
categorized in three groups: classical plasma protein in the range of mg/ml to g/ml, 
tissue leakage product of around ng/ml and interleukins/cytokines of under ng/ml to 
pg/ml. The concentration of prostate specific antigen (PSA), best known plasma 
biomarker, is about 2 ng/ml and prostate cancer risk is indicated above 4 ng/ml, so 
sensitivity of biomarker discovery should be exactly quantitative detection of plasma 
protein in the low range of ng/ml.  
In recent years, the biomarker development by proteomics has been activated.10 
The biomarker discovery promising comprehensive analysis has advanced greatly 
accompanying the rapid advance of mass spectrometric technology and bioinformatics. 
Proteomic approach enables global protein identification, and can be obtained 
systematic data. While such technologies provide a greater understanding of large-scale 
and complex biological event, it has necessitated effective data annotation method and 
simple user interface to link to distinctive biological process. Therefore, the functional 




The process of new biomarker development can be mainly divided into three 
aspects (Table 1).11 First, screening step, proteins by differential analysis are identified 
and classified as biomarker candidate. Second, verification step, biomarker candidate 
was quantified and verified by western blotting or immunohistochemistry by the 
specific antibody. And third validation step, surviving biomarker candidate are validated 
by high-throughput quantification assay for establishment of sensitivity and specificity, 
usually enzyme-linked immunosorbent assay (ELISA). And remaining candidate will be 
next large-scale clinical or cohort study. By advance of MS technology, MS-based 
validation method such as quantitative multiple reaction monitoring (MRM) is being 
established as next generation’s biomarker validation system. 
However, such biomarker strategy is faced on several essential issues. The proof 
of concept on candidate biomarker is very difficult to demonstrate. For example, 
sensitivity and specificity between preexisting biomarkers and novel biomarker or 
combination of biomarkers, correlation between pathobiology and expression change of 
target molecules, evidence of leakage from specific disease tissue or organ by serum 
proteome, possible diagnosis platform as circulating biomarkers or autoantibodies, 
validation of detectable biomarker from serum by tissue proteome, good animal model 
for biomarker development, high-cost performance of antibody dependent validation 
method, these issues are the essential for omics study. And large dataset confuse 







Gene ontology-based statistical data annotation 
 
In the proteomic field, effective data annotation of large-scale dataset is one of the 
essential issues. Data analysis of the large protein dataset is a very important 
downstream task to understand the biological significance of the output proteins. This 
annotation can become it informative or invalid depending on data processing.12 The 
quality of large-scale dataset derived from proteomic studies is one of the most 
important concepts that directly influence the success of the following functional 
analysis. In the complexity of the data-mining situations involved in biological studies, 
there is no good systematic way at present. But a good dataset may exhibit the 
following characteristics:13 
1. Appropriate protein extraction, tryptic digestion and peptide recovery for each 
analytical platform 
2. Reproducible and quantitative dataset of possible confirmation by another 
experimental method 
3. Accurate protein identification by mass spectrometric method (peptide mass 
fingerprinting, MS/MS analysis and precise criteria of database search results or 
verification of protein physicochemical property) 
4. Contain many important proteins in the dataset as expected for objective research 
field 
5. Statistically quantitative cutoff with appropriate number of dataset (100 to 2000 
data, not low or high) 
6. Time-dependent quantitative dataset 
7. Biologically over-representation by up- or down-regulated protein expression 
10 
 
It is very important to understand not only what a kind of targeted biomarker, 
biomarker for response to therapy or prediction of disease risk, post-translational 
modifications as biomarker, but also what biological function, mechanism of disease or 
pathway. So, I focused on functional analysis of proteomic dataset and developed a new 
data mining method based on gene ontology. In this data annotation concept, I will 
propose one of the essential solutions for serum proteomic research. 
The gene ontology database can be freely accessed from the Gene Ontology 
website (GO, www.geneontology.org), Gene ontology annotation (GOA) and Open 
biological ontologies (OBO).14 The GO term and ontology component of OBO was 
divided into three categories; “molecular_function”, “cellular_component”, and 
“biological_process”. I first prepared the data set consisting of a pair of UniProt ID, GO 
ID, term and component. Each UniProt ID and spot quantity can be highlighted to 
correspond to multiple GO IDs. GO analysis was performed and GO terms categorized 
in the “biological_process” component with p < 0.05 as significant terms by 2 test and 
Fisher’s exact test in serial time points. 
In figure 1, schematic flow of the gene ontology based proteomic data annotation 
method. This annotation method provides several strategies to show how and when the 
proteins of interest are distributed among gene ontology terms by statistically 
over-represented biological process. And this makes the overall biological picture 






Table 1. Novel biomarker development process. 





































1. Process for proteomic data acquisition
Figure 1. Scheme for gene ontology based data annotation. 
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New approach for biomarker discovery from the multi-omics: 
 
Potential implications for monitoring serum bile acid profiles in circulation  
with serum proteome  

















Bile acids have recently emerged as versatile signaling molecules, and their 
signaling pathway is a promising target for the treatment of metabolic diseases. Here, I 
developed a highly sensitive and high-throughput quantification method for six taurine- 
and glycine-conjugated bile acids using matrix assisted laser desorption/ionization 
time-of-flight mass spectrometry after solid-phase extraction (SPE-MALDI-TOF MS). 
In a carbon tetrachloride (CCl4)-induced liver injury/regeneration model in mice, serum 
bile acid profiles were monitored, and the same samples were separated by 
two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), and protein spots that 
significantly changed in quantity in a serial time points were identified by MALDI-TOF 
MS. Serum taurocholic acid (TCA) concentration was significantly elevated earlier than 
the increase of serum aspartate aminotransferase (AST)/alanine aminotransferase (ALT) 
activity, a potentially sensitive marker for minimal hepatic damage. Furthermore, TCA 
peaked at 20 h after treatment when massive serum proteins appeared in circulation. It 
should be noted that direct MALDI-imaging mass spectrometry (IMS) has succeeded in 
showing a hepatic lobular distribution change of TCA, predominantly seen in zone 1 
area whereas necrotic changes were dominant in zone 3 area. The in-depth analysis of 
bile acid profiles in circulation with hepatic lobular distribution is a strong basis to 









Bile acids are amphiphilic end products of cholesterol catabolism that facilitate 
lipid absorption in the intestine. Bile acids are synthesized in the liver, released into the 
proximal intestine, and reabsorbed in the distal intestine via the portal vein, a process 
termed enterohepatic circulation.1 Serum bile acid levels therefore vary during the day 
following a rhythm of the ingestion of meals. Based on these observations, systemic bile 
acids are well positioned to inform the peripheral tissues that a meal has been ingested 
and that energy will become available.3, 15-16 Recently, bile acids emerged as versatile 
signaling molecules endowed with systemic endocrine functions. Bile acids are ligands 
for G-protein coupled receptors (GPCR) such as TGR5 and modulate several nuclear 
hormone receptors including farnesoid X receptor (FXR).7, 17 Through activation of 
these versatile signaling molecules, bile acids have been shown to regulate not only 
their own synthesis and enterohepatic circulation, but also triglyceride, cholesterol, 
energy, and glucose homeostasis. These bile acid controlled signaling pathways have 
become the source of promising novel drug targets to treat common metabolic and 
hepatic diseases.5 
Many of the proteins in serum are synthesized in the liver and the abundance and 
structures of these proteins change in response to liver diseases. It is expected to 
facilitate the understanding of liver biological processes and their dysregulations in 
diseased status using the mapping of the liver proteome content.18-19 In addition, the 
discovery of novel biological markers for the early detection of liver disease as well as 
therapy’s efficacy or side effects is urgently needed.20-21 Especially, liver regeneration is 
an important process. Although many regulatory events and their temporal distribution 
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during liver regeneration have been identified to date, the study on single pathways and 
signaling factors has thus far been insufficient to fully delineate the metabolomic 
complexity of the proliferative response after liver injury.22 Several attempts have been 
undertaken to obtain a more global picture of the cellular processes that occur during 
liver regeneration. Animal models are available, which include a liver regeneration 
model induced by partial hepatectomy (PHx) and carbon tetrachloride (CCl4).23-26 
Even with the current proteomic technologies with wide quantitative range, 
complexity of serum protein expression often requires multiple platforms.9, 27 In 
addition, a big debate in the clinical proteomics field is which type of sample, blood or 
tissue, should be used to discover serologic biomarkers. Proteomic studies using blood 
still have not resolved the question of whether plasma or serum can serve as a window 
into the state of patients’ disease, and there is currently no scientific evidence that a 
linear relationship exists between protein changes in diseased tissue and protein changes 
in blood. Recent advances in high-throughput proteomics have made it possible to 
profile the global compositions of entire tissues, organelles, or interactomes at specific 
time points or under particular developmental or disease states. While such methods 
provide researchers with a greater understanding of large-scale, complex biological 
changes to overcome greater dynamic range such as serum proteome, it has necessitated 
an increasing reliance on standardized annotation to link results to known biological 
activities. Therefore, the functional classification of identified proteins is critical for 
proteomic studies aimed at discovering disease biomarkers. 
Consistent with these notions, here I try to cross-validate bile acid homeostasis 
and serum proteome. Historically, bile acid analysis has been hindered by difficulties in 
separating many structurally similar compounds and isomers in a highly complex matrix. 
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Lately, LC-MS has been shown to be a sensitive and quantitative method of analysis for 
identification of major bile acids in urine and plasma.28 I have developed and shown 
here a modified bile acid-targeted profiling method by solid phase extraction-based 
sample pretreatment and subsequent MALDI-TOF MS analysis,29 giving superior 
specificity and a high-throughput analysis. I applied this method to the systemic 
analysis of the CCl4-induced acute liver injury/regeneration model resulting in 
comprehensive profiling of both serum proteome and serum bile acid metabolome. In 
addition, the serum bile acid profiles were also validated by direct imaging mass 
spectrometry on liver histology.30-31 This in-depth analysis of the bile acid profiles and 
corresponding serum proteomes provides a strong basis for investigations of liver 
pathobiology that employ mouse models of acute liver injury/regeneration in an effort to 















Materials and methods 
 
Chemicals 
Transaminase C-II test kit (L-Type GOT/J2 aspartate aminotransferase kit, 
L-Type GPT/J2 alanine aminotransferase kit) and mass spectrometry grade 
recrystallized -cyano-4-hydroxycinnamic acid was purchased from Wako Pure 
Chemical (Osaka, Japan). Glycocholic acid (GCA), glycochenodeoxycholic acid 
(GCDCA), glycolithocholic acid (GLCA), taurocholic acid (TCA), 
taurochenodeoxycholic acid (TCDCA), and taurolithocholic acid (TLCA) were from 
Steraloids (Newport, RI) as sodium salts. 9-Aminoacridine hemihydrate (9-AA) was 
from Acros Organics (Geel, Belgium). N-1-Naphthylphthalamic acid (NPA) was from 
Fluka (Buchs SG, Switzerland). Empore 96-well disk plates C18-SD were from 3M (St. 
Paul, MN). Indium-tin oxide (ITO) coated glass slides (8-12 Ω/sq) were from 




This study was approved by the Ethics Committee of Kyoto Prefectural 
University of Medicine (Document number M21-164). Five-week-old male ICR mice 
(body weight 23-25 g, CLEA, Japan) were maintained on a fixed artificial light cycle 
(12 h of light and 12 h of dark) with free access to water. CCl4 was mixed with mineral 
oil at a dose of 1 mg/kg body weight and injected intra-peritoneally. Serum samples 
were collected at serial time points of 0, 1, 3, 6, 12, 20, and 48 h after CCl4 
administration from orbital venous plexus. Seven and six mice were fed for CCl4 i.p. 
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and mineral oil i.p. control, respectively. Samples were kept frozen at -80 °C until use. 
At each time point, livers were removed and kept frozen until further analysis. Serum 
AST/ALT activity was measured with transaminase C-II test kit. Frozen tissue samples 
were sliced with a thickness of 10 μm using a cryostat microtome (Leica, Germany). 
Histological images were obtained by a simple optic density method and hematoxylin 
and eosin and Oil Red O staining. Imaging was obtained by microscope (TE300-EF, 
NIKON, Japan). 
 
Bile acid quantification  
Bile acid standard concentration was 4-1000 μg/mL for glycine conjugate (GCA, 
GCDCA, GLCA) and 0.3-160 μg/mL for taurine conjugate (TCA, TCDCA, TLCA) in 
ethanol, and 100 μL of standard solution was mixed in 1.8 mL of deionized water. Bile 
acid solution was purified using Empore 96-well disk plates C18-SD and eluted with 
150 μL of methanol. A serum sample of about 50 μL was also dissolved in 1.8 mL of 
water and 100 μL of ethanol was added. Eluate was mixed in an equal volume of 28 
μg/mL N-1-naphthylphthalamic acid (NPA) and 10 mg/mL 9-aminoacridine (9-AA) in 
methanol and spotted on a MALDI target plate. MS data of bile acids was obtained by 
automated data acquisition and internal calibration with deprotonated signals from NPA 
(m/z 290.08) and 9-AA (m/z 193.08) in the same well using an AXIMA CFRplus 
MALDI-TOF MS (Shimadzu, Japan). Peak intensity was calculated by peak area 
integration and was normalized by NPA signal in same spectrum. Peak intensity was 
averaged from four measurements. Calibration curve was generated from the 
normalized intensity of each bile acid standard concentration, and the concentration was 





Serum proteins were separated by two-dimensional polyacrylamide gel 
electrophoresis (2-D PAGE). The procedures for proteomic analysis were carried out as 
described previously.32 Briefly, serum protein concentration was determined by 
Bradford reagent (Sigma-Aldrich), and 300 μg of protein was dissolved in isoelectric 
focusing (IEF) buffer (6 M urea, 2 M thiourea, 3% CHAPS, 1% Triton X-100 and 1% 
DeStreak reagent) by gentle vortexing for 30 min at room temperature. A 13 cm 
DryStrip gel of nonlinear pH 3-10 gradient was used for IEF using an IEF Cell (BioRad, 
Hercules, CA). After IEF, the DryStrip gel was equilibrated in sample buffer (6 M urea, 
2% SDS, 20% glycerol, 2% DTT, and 375 mM Tris-HCl, pH 8.8) for 20 min, and a 
10-16% polyacrylamide gradient gel was used for the SDS-PAGE. Protein spots were 
visualized with high-sensitivity CBB G-250 solution, and gel images were acquired 
using a GS-800 calibrated imaging densitometer (BioRad). Protein spot analysis was 
performed by PDQuest, version 7.2, 2-D analysis software (BioRad). Protein spots were 
excised and digested in-gel with trypsin after reductive alkylation with DTT and 
following iodoacetamide. After incubation at 37 °C overnight, tryptic peptides were 
desalted with ZipTip μC18 (Millipore, Billerica MA). Recrystallized -cyano-4- 
hydroxycinnamic acid (10 mg/mL in 0.1% trifluoroacetic acid and 50% acetonitrile) 
was used as MALDI matrix. 
Protein identification was performed by peptide mass fingerprinting (PMF). 
Peptide masses were analyzed using an AXIMA CFRplus MALDI-TOF MS. The 
acquisition mass range was 650-4000 Da. The equipment was first externally calibrated 
by protonated mass signals of a five peptide mixture, bradykinin fragment 1-7 
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(monoisotopic m/z 757.40), angiotensin II (m/z 1046.54), P14R synthetic peptide (m/z 
1533.86), ACTH fragment 18-39 (m/z 2465.20), and insulin oxidized B chain (m/z 
3494.65). Each data point was internally calibrated by protonated signals from tryptic 
autolysis fragments (m/z 842.51 and m/z 2211.10). The raw spectrum data was opened 
by Mascot Distiller, version 2.2.0, peak picking software (Matrix Science, London) and 
processed by default parameters. Protein was identified against UniProt (June 10, 2008; 
389 046 Mus musculus sequence entries) and NCBInr (September 7, 2008; 7 020 262 
non-redundant mammalian sequence entries) database on Mascot Server, version 2.2, up 
to one missed cleavage, peptide tolerance of 0.2 Da, fixed modifications of cystein 
carbamydomethylation, and variable modifications of methionine oxidation. MOWSE 
scores above 54 for UniProt and 71 for NCBInr were considered significant (p < 0.05). 
 
Use of gene ontology in serum proteome 
Identified proteins were further annotated using gene ontology to perform 
functional analysis. The GO database can be freely accessed from the Gene Ontology 
website (www.geneontology.org), Gene ontology annotation (GOA) and Open 
biological ontologies (OBO).14 The GO term and ontology component of OBO was 
divided into three categories; “molecular_function”, “cellular_component”, and 
“biological_process”. I first prepared the data set consisting of a pair of UniProt ID, GO 
ID, term and component. I used in this data set the gene_ontology_edit. obo (Feb. 26, 
2009) and the gene_association.mgi (Feb.26, 2009). In case proteins did not fit to Mus 
musculus, gene_association.rgd and gene_association.goa_human were used. Each 




Statistical analyses  
Differentially expressed protein spots on 2D gels corresponding to CCl4 
administration were selected widely by comparison with average of seven CCl4-treated 
samples against six control samples using PDQuest. Each volume of selected spot was 
refined by the one-way analysis of variance (ANOVA) test using GeneSpring GX, 
ver.10, gene expression analysis software (Agilent, Santa Clara, CA). From the 
two-step-criteria, about 250 protein spots of statistically significant change and serial 
time points were selected as the candidates for further analysis. GO analysis was 
performed using GeneSpring, and GO terms categorized in the “biological_process” 
component with p < 0.05 as significant terms by 2 test and Fisher’s exact test13 in 
serial time points. 
 
Imaging mass spectrometry (IMS)  
Frozen liver tissues were sliced with a thickness of 10 μm, and the section was 
attached onto ITO coated glass slides. Using a chemical inkjet printer CHIP-1000 
(Shimadzu), a mixed solution with 10 mg/mL 9-AA and 6 μg/mL NPA in 10% 
2-propanol and 80% methanol was printed over the tissue section at a spatial interval of 
200 μm as 50 iterations at 300 pL per iteration. MS data was obtained using an AXIMA 
Performance MALDI-TOF MS (Shimadzu). Automated data acquisition was performed 
for each matrix deposit. Deprotonated signals of 9-AA and angiotensin II (m/z 1044.52) 
were used for external calibration. An electrical image of each section on the target plate 
was scanned using CHIP-1000. The obtained mass spectra were converted, for selected 
m/z value, into comma-separated values (CSV) associating signal intensity with XY 
coordinate. The ion image highlighted the signal intensity obtained from a specific 
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molecule. Peak intensity was normalized by NPA standard in the same spectrum. These 
specific ion images for compounds of interest were displayed by plotting the spacial 


























Assessment of CCl4-induced liver injury / regeneration model 
The serum biochemical markers for CCl4-induced liver injury/regeneration model 
were measured at 0, 1, 3, 6, 12, and 20 h after administration (Figure 1a, b). 
Conventional serum AST/ALT activity indicated that an acute liver injury could be 
diagnosed 6-12 h after CCl4 administration when both activity markers were markedly 
increased.  
Because ideal attributes of biomarkers for liver damage include organ specificity 
for liver, histological analysis is essential. According to the previous study, I scored 
histopathology of the liver from “0” to “V” in order of increasing damage and 
regeneration; 0, no observed necrosis; I, a few degenerating parenchymal cells; II, 
minimal necrosis; III, extensive necrosis in which central veins were surrounded by 
several layers of dead or degenerating cells; IV, massive necrosis of extensive liver 
areas; V, regenerative stage.33 I observed for time 0 h, 0; 1 h, 0-I; 3 h, I-II; 6 h, III; 12 h, 
IV; 24 h, IV-V; and 48 h, V. These observations were based on our histopathology 
shown in Figure 2a, b. 
 
Quantification of serum bile acid  
Quantitative analysis by MALDI-TOF MS has been demonstrated for compounds 
of biological interest. In the previous study, the bile acids were separated from urine by 
SPE cartridges and quantitative analysis by MALDI-TOF MS.29 I demonstrated 
quantification of bile acids at biologically relevant concentrations directly from serum 
with minimal sample preparation. Dynamic range of bile acid concentration in serum by 
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our method was 4-1000 μg/mL for glycine conjugates and 0.3-160 μg/mL for taurine 
conjugates (Supporting Information). 
Concentrations of six cholic acid conjugates, TCA, TCDCA, TLCA, GCA, 
GCDCA, and GLCA, in murine serum were determined (Figure 3a-f). TCA 
concentration was markedly elevated as liver injury progressed, significantly from 3 h, 
reaching a maximum at 20 h after administration. After 48 h, it remained at a higher 
level than that of the normal control. Serum TCDCA concentration was also elevated 
significantly from 6 h and reached a maximum at 20 h, as I have shown in the TCA 
profile. However, the amplitude of its change is much smaller, about 1/50. Serum TCA 
and TCDCA of control mice did not show any increase during the experiments. 
Secondary bile acid, TLCA and GLCA, did not show any significant change. With these 
observations, taurine-conjugated primary bile acids TCA and TCDCA could be defined 
as biomarkers for acute liver injury. 
In Table 1, I showed serum concentration ratio of [TCA]/[TCDCA], which is 
adjusted by control mouse value in each time point. As liver injury progresses, the ratio 
increased up to 16.6 at 3 h and reached as high as 71.0 at 12 h, and then decreased to 
24.4 at 48 h. It is notable that such an elevation of serum [TCA]/[TCDCA] was 
sustained more than 2 days. 
 
Serum proteome 
More than one hundred densitometric features were reproducibly detected on each 
2-D PAGE for each mice serum (Supporting Information). Serum proteins as quantified 
by differential 2-D PAGE seemed remarkably stable in the absence of liver injury since 
so few changes were observed from 0 to 1 h. However, during the time of high toxicity 
26 
 
with a known liver injury dose of CCl4 as determined by histopathology and AST/ALT 
activity (Figure 1), differential proteomic analysis showed the greatest number of serum 
protein changes (Table 2 and Supplementary Table, Supporting Information). 
According to our proteomic data, alterations in serum bile acid metabolites and 
serum proteins are well correlated. From 6 to 12 h after CCl4 administration, the change 
rate of bile acids and increase number of serum proteins were most prominent and 
reached maxima at 6-12 h. In earlier time points before 6 h, 12 up-regulated and 3 
down-regulated proteins belonging to above criteria are as follows: up-regulated at 1 h, 
OBP2A; up-regulated at 1-3 h, Hspa5, Fgb, Saa2, Psma2, and Aldoa; up-regulated at 3- 
6 h, Fbp1, Saa2, Ald, Gpd1, Idh1, and Fah; down-regulated at 1-3 h, Gsn; 
down-regulated at 3-6 h, Fgb and Psma2 (Table 2 and Supplementary Table, Supporting 
Information). 
 
Applying GO into serum proteomics 
All identified proteins were translated into GO terms as described in OBO, and 
the results are shown in Figure 4. Apparently, I can discriminate time-dependent 
histological events of this hepatotoxicity model according to GO statistical analysis. For 
acute phase, several proteins have started to become up-regulated and a few proteins 
were down-regulated, mostly belonging to acute response. As for blood regulation and 
actin regulation, some were up-regulated and some were down-regulated. 
The most prominent changes in serum proteins were observed between 6 and 12 h 
after CCl4 treatment. I can call it a fulminant liver injury stage. More than 150 proteins 
belonging to amino acid metabolism were over-represented in serum. And at this time 
point only, proteins concerned with regulation of programmed cell death appeared in 
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serum. Although proteins of amino acid metabolism continued to be over-represented 
until 20 h, proteins of oxidative reduction, protein metabolism, and carbohydrate 
biosynthesis were underrepresented. From 20 h, some proteins concerned with 
regeneration, regulation of immune system processes, organic acid metabolism, and 
lipoprotein metabolic processes were overrepresented. 
 
Imaging mass spectrometric analysis  
Direct MS/MS fragment pattern analysis from liver section was performed to 
demonstrate that mass signals of m/z 514 and m/z 498 were derived from TCA and 
TCDCA, respectively (Figure 5a, b and Supporting Information). The ion images 
constructed from these signals on normal control and pathological liver tissue sections 
are shown in Figure 6a-d. In 6 and 20 h after CCl4 administration, the ion images for 
m/z 514 were strongly elevated diffusely all over the liver section. As a control, there 
are few signals in normal control liver. Of note, the peak from TCA was noticeable in 
accordance with portal vein structure in the normal control liver (Figure 6, circled). 
Hepatic lobular structure that TCA could be detected was around portal vein, not central 
vein (Figure 6). While TCA and TCDCA were successfully detected on liver sections, 
peaks from TLCA, GCA, GCDCA, and GLCA were not detected (data not shown). In 3 
h IMS data (white arrow in [TCA, 3 h]), ectopic TCA signals were observed not related 
to hepatic lobular structure, which might be blood contamination in dissection. 
Furthermore, I tried to perform semi-quantitative analysis of TCA and TCDCA directly 
from liver section (Supporting Information). TCA and TCDCA profiles on tissue were 
similar to serum one except for at 12 h, because ionization suppression occurred by 
large amount of signals such as phosphatidylethanolamine. 
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With all these findings of imaging mass analysis, I may say that TCA in the acute 
phase of CCl4-induced liver injury is well correlated with the serum profile of TCA as 


























In this study, I demonstrated that serum bile acid profile can be a diagnostic 
marker for liver injury/regeneration in the CCl4-induced mouse model. This is indicated 
by a novel and informative biomarker strategy integrating time and space distribution of 
bile acids in circulation. To our knowledge, this is the first study to apply imaging mass 
spectrometry to cross-validate serum biomarkers directly on the diseased tissue. 
Importantly, simultaneous measurement of changes in multiple serum proteins and bile 
acid metabolites made it possible to explore connections between proteomic and 
metabolomic changes in acute, fulminant, and recovery course of hepatotoxicity. One of 
the remarkable findings of this investigation is the significant elevation in serum TCA in 
acute to fulminant liver injury above the physiological level. Previous studies showed 
that CCl4 toxicity can be assessed by serum AST/ALT activity at 6-24 h (AST) or 6-36 h 
(ALT) in a time-dependent manner,23-24 which is also reproduced in our study. As serum 
concentrations of TCA become elevated from 3 h after CCl4 administration, profiling 
serum bile acids is more sensitive than a classical AST/ALT activity. 
CCl4-induced hepatotoxicity is characterized by increased oxidative stress leading 
to increased lipid peroxidation.34 In the present study, expressions of some proteins were 
up- or down-regulated in the acute phase, meaning that these are empirical serum 
protein biomarkers for acute hepatotoxicity of CCl4. For example, in 1-3 h after CCl4 
administration, serum gelsolin was significantly down-regulated. Because other critical 
situations exist that cause circulating gelsolin to decrease in plasma by forming 
actin-gelsolin complexes, gelsolin is not a hepatotoxicity-specific marker.35 Serum 
amyloid A-2 is also up-regulated in the acute phase in the present model, but it is a 
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well-known responder to various tissue injuries.36 Interestingly, odorant binding protein 
Ia, which appeared in serum in a very acute time course, is not implicated in acute 
response, so it can be a novel protein biomarker candidate.37 Fibrinogen beta chain was 
up-regulated from 1 to 3 h in serum with a subsequent decrease before 6 h. This clearly 
shows how blood coagulation contributes to the pathogenesis of CCl4-induced liver 
injury. There are some decreased proteins in a recovery phase; mannose binding protein 
C and plasma retinol binding protein38 can be recognized as protein markers for the 
recovery phase of this hepatotoxicity model. 
Assuming that these proteins are candidates for serum biomarkers of acute liver 
injury, they must be interpreted in a systemic background.15 For example, the relation 
between liver gene expression profiles and CCl4 hepatotoxicity has been well studied in 
toxicogenomics. In this study, I applied GO statistical analysis in serum proteomics in 
making a whole map to understand proteome-wide alterations in serum in response to 
CCl4. Serum proteomics with GO annotation can further give us information about 
histological events of liver from acute to regenerative phases. Based on gene expression 
in the CCl4-administered rats, maximal toxic time was estimated to be 6 h from the 
analysis of hierarchical clustering.23 It is interesting to note that up-regulated genes 
peaks at 6 h after CCl4 administration and soon returned to normal levels within 12 h. 
With our proteomic data, massive protein alteration started from 6 h to end in 12 h, 
mostly classified into amino acid metabolism, apoptosis, and regeneration. This is fairly 
understandable because proteins of amino acid metabolism are tightly linked to a proper 
liver function of the periportal area. In addition, histopathology has shown that CCl4 
induces necrosis and apoptosis around the central veins. This is clearly reflected in the 
heat map chart of GO over-representation. Before this massive change, I can pick up 
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some acute reactant proteins, as well as proteins concerned with apoptosis. Most 
importantly, GO analysis on serum proteomics clearly demarcated that regeneration 
started from 12 h after CCl4 exposure. 
The heterogeneity of liver histochemistry is related to the blood supply; cells 
located in the upstream or periportal zone differ from those in the downstream or 
perivenous zone in their equipment with key enzymes, translocators, receptors, and 
subcellular structures and therefore have different functional capacities. This is the basis 
of the model of metabolic zonation, according to which glucose release from glycogen 
and via gluconeogenesis, amino acid utilization and ammonia detoxification, TCDCA 
can be detected on the tissue sections from 3 h after CCl4 administration. It is important 
to note that liver 12 h after CCl4 administration is full of many different molecular 
species such as phospholipids (Supporting Information). In normal control liver, I can 
observe vascular-shaped regions of TCA protective metabolism, bile formation, and the 
synthesis of certain plasma proteins such as albumin and fibrinogen occur mainly in the 
periportal area, whereas glucose utilization, xenobiotic metabolism, and the formation 
of other plasma proteins such as R1-antitrypsin or R-fetoprotein occur predominantly in 
the perivenous zone.39 Recent developments in MALDI-MS have enabled direct 
detection of lipids as intact molecular species present within cellular membranes.31 
Abundant lipid related signals are produced from the direct analysis of tissue sections 
when sequential spectra are acquired across a tissue surface that has been coated with a 
MALDI matrix. As I expected, peaks responsible for TCA and much less with elevation 
(Figure 6, circled). This can be a portal vein, reflecting enterohepatic circulation of TCA. 
In later time course, zonal distributions of TCA become much prominent. At 3 h after 
CCl4 treatment, a bile flow from portal vein is clearly demarcated from surrounding 
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lobular organization as shown in Figure 6.40-41 At 6 h later, TCA distribution patterns 
spread all over the liver, and this continues to 20 h after CCl4 treatment. 
Bile acid metabolism plays a critical role for the elimination of excess cholesterol 
in the liver.1, 3 This pathway is achieved via transcriptional regulation of cholesterol 
7a-hydroxylase (CYP7A1), the limiting enzyme of bile acid biosynthesis.4 Upon bile 
acid stimulation, a member of nuclear receptors (NRs), FXR, potently activates 
transcription of the small heterodimer partner, SHP, which is an atypical orphan NR 
lacking a DNA binding domain.5, 42 On its activation by bile acids, FXR regulates bile 
acid synthesis, conjugation, and transport, as well as various aspects of lipid and 
glucose metabolism. This means that in the regenerative phase of the CCl4-induced liver 
injury model, bile acids can contribute to successive gene expression of the hepatocytes, 
which is concerned with feedback regulation of bile acids itself. Recently, in vitro and in 
vivo data showed that bile acids modulate gluconeogenesis by regulating the expression 
of the rate-controlling enzyme phosphoenol pyruvate carboxykinase (PEPCK), as well 
as of glucose-6-phosphatase (G6Pase) and fructose-1,6- bisphosphatase (FBP1).43 Our 
proteomics data have suggested that the FXR driven proteins via SHP were 
down-regulated in the recovery phase of the present model, such as FBP1 and ApoA1.5 
Before translating these observations into human study, I must think about 
species-specific differences of bile acid metabolism. For example, previous research has 
shown that the effect of bile duct ligation on the total bile acid synthesis appears to be 
different between rats and hamsters.44 Amidation of bile acids in the liver requires the 
sequential action of two separate enzymes, bile acid CoA synthetase (BAS) and bile 
acid CoA:amino acid N-acyl-transferase (BAT).45 In the first reaction, BAS catalyzes 
the formation of bile acid CoA thioesters. In the second reaction, BAT catalyzes the 
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reaction between the bile acid CoA thioester and either taurine or glycine. In case of 
mouse, mBAT uses taurine but not glycine as a substrate for the conjugation of bile 
acids, which was totally proven by the present study. However, rat and human 
synthesize both taurine- and glycine-conjugated bile acids.2 Besides their well 
established roles in dietary lipid absorption and cholesterol homeostasis, it has recently 
emerged that bile acids are also signaling molecules, with systemic endocrine functions. 
It must be important to monitor bile acid profiles in terms of systemic approaches for 
metabolic perturbed situations such as diabetes and hypertriglycemia before and after 
preclinical drug development. It is extremely important to monitor serum bile acid 
profiles in the clinical trials of novel drug development in the category of FXR agonists, 
modulators, bile acid pool modulators, and TGR5 agonists.5 In addition, targeted 
metabolomics applied to analyze the role of genetic variants on bile acid profiles in a 
large human population will be a very powerful approach in the future. 
In conclusion, the present study demonstrated that bile acid profiling would be a 
promising biomarker that may help to evaluate therapeutic risks, efficacy, and drug 













Table 1. Adjusted serum TCA/TCDCA concentration ratio.  
Adjusted ratio of serum TCA to TCDCA concentration of CCl4 treated mice compared 









Table 2. Scoring histopathology of CCl4-induced liver injury/regeneration model 
with corresponding serum proteomic data. 
At 0, 1, 3, 6, 12, 20, and 48 h after CCl4 treatment, images of liver histology based on a 
simple optic density method are indicated. Scoring (zone) represents scoring of 
necroinflammatory activity of this model according to histology activity index (HAI) of 
the Scheuer System,33 which is modified as follows. Grades 0 to 4 represent 0) no or 
minimal change, 1 = inflammation but no necrosis, 2 = mild or focal necrosis, 3 = 
moderate necrosis or severe focal cell damage, 4 = severe necrosis or damage including 
bridging necrosis. Serum proteome indicates the up- and down-regulated protein ID or 
number of identified protein. 
Time 0hr 1hr 3hr 6hr 12hr 20hr 48hr
Ratio 0.6 5.6 16.6 31.0 71.0 50.3 24.4
Time Histology Scoring(Zone) Serum proteome
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Figure 1. Asparatate and alanine aminotransferase activity in mouse serum.  
Time-dependent enzymatic (a) AST and (b) ALT activity of CCl4-administrated serum 
(solid) and control (dotted) is demonstrated using a transaminase test kit. Single and 
doubled asterisk indicate p < 0.05 and p < 0.01, respectively. 
 
Figure 2. Histopathological image of mouse liver section.  
Histological images were obtained at each serial time point of 0, 1, 3, 6, 12, 24, and 48 
h after CCl4 administration by (a) HE staining image and (b) Oil Red O staining. 
Typical histopathological observations of CCl4-induced liver injury/regeneration model 
are obtained. From image of 0 h, normal hepatic lobular structure was observed, and 
shape of hepatocyte was slightly changed in 1 h. Hepatocyte ballooning and 
inflammation was observed in 3 h, and mild necrosis around portal vein was occurred in 
6 h. Fatty degeneration or necrosis was advanced at 6-12 h, and massive necrosis and 
cell damage occurred in 20 h. In 20 h, some hepatocyte regeneration seemed to begin 
around the portal vein. In 48 h, hepatic lobular regeneration was observed from the 
portal vein, but necrosis or fatty degeneration remained around the central vein. 
 
Figure 3. Time-dependent quantitative profile of serum bile acids.  
Serum samples were measured at 0, 1, 3, 6, 12, 20, and 48 h after CCl4 administration: 
(a) TCA in CCl4 (solid) and control (dotted); (b) TCDCA in CCl4 and control; (c) TLCA 
in CCl4 and control, (d) GCA in CCl4 and control; (e) GCDCA in CCl4 and control; f) 
GLCA in CCl4 and control. Y-axis of taurine conjugate was the range of 0-20 μg/mL 
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except for TCA, and glycine conjugate was 0-120 μg/mL, which is 1/8 of each dynamic 
range. A t test was carried out for each time point vs the previous time point. Single and 
doubled asterisk indicate p < 0.05 and p < 0.01, respectively. 
 
Figure 4. Gene ontology based biological process representation.  
Over-represented GO terms with p < 0.05 of “biological_process” in a serial time points 
are shown with two-color heat map chart: color scale indicates significant GO terms 
associated with over-represented proteins (yellow) and under-represented proteins 
(blue), and no-signal is indicated by black. The major biological process is indicated in 
the left column of Process. Proteins used in this analysis are shown in the 
supplementary table, Supporting Information.  
 
Figure 5. Direct MS/MS analysis from liver section of TCA and TCDCA.  
MS/MS spectrogram of (a) TCA and (b) TCDCA were obtained by AXIMA Resonance 
MALDI-quadrupole ion trap-TOF MS (Shimadzu). The lower spectrogram shows TCA 
and TCDCA standard, and the upper one shows TCA and TCDCA signal directly from 
liver section at 6 h. The distinct fragment ion derived from taurine (m/z 124) is shown 
in each MS/MS signal. A dehydration fragment ion from steroid basic structure is also 
observed. 
 
Figure 6. Imaging mass spectrometric analysis of TCA and TCDCA on liver 
section.  
TCA and TCDCA distribution image was obtained from liver frozen section at (a) 0, (b) 
3, (c) 6, and (d) 20 h after CCl4 administration. Each image is marked as follows: [TCA] 
38 
 
TCA distribution; [TCDCA] TCDCA distribution; [HE] HE staining image of serial 
section of IMS; [HE circled] HE image around circled area of TCA signal elevation; 
[IMS image] acquired section image of IMS. Circled area indicates around portal vein, 
and white arrow in [TCA, 3 h] of (b) is ectopic TCA signals. Scale bar indicates 2 mm. 
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Supplementary figure 1. Chemical structure of bile acids and other reagents for 
MS.  
Six bile acid standard of a) GCA (glycocholic acid, MW = 465.62), b) GCDCA 
(glycochenodeoxycholic acid, MW = 449.62), c) GLCA (glycolithocholic acid, MW = 
433.62), d) TCA (taurocholic acid, MW = 515.70), e) TCDCA (taurochenodeoxycholic 
acid, MW = 499.70) and f) TLCA (taurolithocholic acid, MW = 483.71) are shown. g) 
NPA (N-1-naphthylphthalamic acid, MW = 291.30) is used as internal standard of 
SPE-MALDI-TOF MS analysis. h) 9-AA (9-aminoacridine, MW = 194.23) is as 
MALDI matrix for bile acid detection. 
 
Supplementary figure 2. Calibration curve of six bile acids. 
Bile acid calibration curve are shown. Upper panel is of GCA (solid), GCDCA (dotted), 
GLCA (wide dotted), and lower of TCA (solid), TCDCA (dotted) and TLCA (wide 
dotted). Each bile acid calibration curve is on secondary function with R2 > 0.99, 
possibly because of correlation with abundance of sample and ionizing acceleration by 
local heat generation by laser irradiation: 
GCA; Y = 0.1141 X0.5216 (R2 = 0.998), 
GCDCA; Y = 0.1162 X0.4957 (R2 = 0.996), 
GLCA; Y = 0.1118 X0.492 (R2 = 0.992), 
TCA; Y = 0.8405 X0.6713 (R2 = 0.998), 
TCDCA; Y = 0.8564 X0.6676 (R2 = 0.999), 




Supplementary figure 3. Representative SPE-MALDI-TOF MS spectra from 
serum bile acids. 
Raw MS spectra of serum bile acid profile are shown in this figure from 0 to 48 h after 
a) CCl4 i.p. and b) mineral oil i.p. control. Significant change of MS signal from TCA 
(m/z 514.3) and small change of TCDCA was obtained in CCl4 i.p. group, but no 
change was observed in control. MS signal of m/z 290.1 was from internal standard of 
NPA. 
 
Supplementary figure 4. Representative images of time-dependent serum proteome 
on CBB G250-stained 2D-PAGE gel. 
Collected serum at each time point was developed on 1st dimensional IEF of pH 3-10 
and 2nd dimensional 10-16% SDS-PAGE. All gels were visualized by high-sensitive 
CBB G-250 staining solution. a) Control group (6 samples) and b) CCl4 administration 
group (7 samples). 
 
Supplementary figure 5. Pattern analysis of structural isomers of TCA by MS/MS. 
From the bottom, TCA, Taurohyocholic acid (THCA) and Tauro-α-muricholic acid 
(TAMCA) were indicated. Structural isomers of TCA, Taurohyocholic acid and 
Tauro-α-muricholic acid, were analyzed by MS/MS fragment assignment using AXIMA 
QIT. MS/MS fragment peaks were indicated the individual patterns of each molecule by 
the vicinal hydroxyl group direction. Major and secondary fragment peak pattern 





Supplementary figure 6. MS spectra of TCA and other metabolite profile on liver 
section. 
Major MS spectra of TCA, UDP-N-acetyl glucosamine (UDP-N-AG) and 
phosphatidylethanolamine (PEs) were obtained from liver section at 0, 6, 12 and 20 h. 
At 12 h, ionization suppression effect occurred by large amount of signals such as m/z 
762 possibly from PEs, for example appeared on surface of the liver reflecting massive 
necrosis. 
 
Supplementary figure 7. Time-dependent semi-quantitative profile of bile acids on 
liver section for challenging quantitative analysis on imaging mass spectrometry. 
In order to evaluate the peak intensity for six bile acids at each time point, direct 
measurement was performed for eight matrix deposits onto each liver section. Matrix 
solution was micro dispensed using CHIP-1000 as described in manuscript. Eight 
deposit areas of m/z 514 and m/z 498 with 25% trim-mean were normalized by a peak 
area of NPA in same spectrum. TCA and TCDCA profile on liver section were shown at 
0, 1, 3, 6, 12, 20, 48 h after CCl4 administration.   
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In this study, I focused on ‘from omics to multi-omics’ for a new mass 
spectrometry-based biomarker discovery to be definite the output: basic or clinical 
output. The quality of large-scale dataset derived from proteomic studies is one of the 
most important concepts that directly influence the success of the following functional 
analysis. So, I propose essential solution for data mining method for proteomic research. 
1) Appropriate protein extraction, tryptic digestion and peptide recovery for each 
analytical platform. 2) Reproducible and quantitative dataset of possible confirmation 
by another experimental method. 3) Accurate protein identification by mass 
spectrometric method (peptide mass fingerprinting, MS/MS analysis and precise criteria 
of database search results or verification of protein physicochemical properties and 
post-translational modifications). 4) Contain many important proteins in the dataset as 
expected for objective research field. 5) Statistically quantitative cutoff with appropriate 
number of dataset (100 to 2000 data, not low or high). 6) Time-dependent quantitative 
dataset. 7) Biologically over-representation by up- or down-regulated protein expression. 
By this concept, it came to understand an important biological event at each time point 
with statistically significant change using gene ontology annotated proteomic dataset, 
and the researcher became possible to know to which event focus had to be done. I will 
propose one of the essential solutions for serum proteomic research. 
Next, this proteomic dataset only is insufficient for the development of clinical 
biomarker. Clinical biomarkers have of at least 3 potential to diagnose criteria:46 First, 
reference limits are generated with the use of cross-sectional analyses of a reference 
sample with an arbitrary percentile cut-points. Second, discrimination limits are also 
used to indicate abnormal biomarker values with evaluating the degree of overlap 
between patients with and without disease in cross-sectional studies. And third, risk 
84 
 
threshold is to define “undesirable” biomarker levels on follow-up by relating values to 
the incidence of disease and seeking a threshold beyond which risk escalates. 
Especially, for informative biomarker in the field of hepatic disease, it is 
necessary to identify the molecules that are directly relationship on the liver 
pathobiology. I consistently used the same serum sample from acute to regenerative 
phase, and focused on serum bile acid metabolome. In this biomarker strategy, I was 
carried out three new concept and technology: 1) serum proteomic dataset as supporting 
information of disease organ pathobiology, 2) development of MS-based simple and 
high-throughput quantification method for serum bile acid, and 3) imaging mass 
spectrometry as cross-validation of serum biomarker on the disease tissue. In this 
approach, I demonstrated that serum bile acid profile can be a diagnostic marker for 
liver injury/regeneration in the CCl4-induced mouse model. And this strategy is 
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